Latest Revenue Performance News

Control Bionics is on track for its strongest financial year yet, driven by robust US and Australian sales and promising global trials of its NeuroStrip® device.

Little Green Pharma invites shareholders to a detailed FY2025 financial results webinar, promising insights into profitability, revenue growth, and recent financing achievements.

Chorus Limited’s 2024 fibre regulatory report reveals a stable $5.9 billion asset base and revenue close to the maximum allowed, with a $153.5 million wash-up balance carried forward.

The Australian Wealth Advisors Group has deepened its Equity Partnership Scheme with strategic stakes in Oneledger and B2B Invest, setting up royalty revenue streams that align with its expansion in financial services.

oOh!media Limited reports robust revenue growth momentum continuing into 2025, driven by strong contract wins and disciplined cost management. The company expects sustained market share gains in the expanding Out of Home advertising sector.

Deterra Royalties Limited reported a 4% increase in portfolio revenue to AUD 61.9 million for the March 2025 quarter, driven by robust iron ore royalties and record gold margins. The company also marked a major milestone with the Final Investment Decision and full funding secured for Phase 1 of the Thacker Pass Lithium Project, targeting production in 2027.

ImpediMed Limited has locked in a US$15 million growth capital facility with SWK Funding LLC, providing crucial financial flexibility to advance its SOZO Digital Health Platform and commercial ambitions.

Noumi Limited’s Q2 FY25 results reveal a resilient plant-based milks segment driving growth, even as traditional dairy and nutritionals face margin pressures amid a challenging market.

Entertainment Rewards Ltd has reported its strongest quarterly revenue performance in over three years, driven by growth in Gift Cards, Paid Advertising, and its Frequent Values program, while continuing to invest heavily in marketing and sales.

ADX Energy reported steady production with 218 BOEPD and A$2.3 million revenue in Q4 2024, while progressing exploration in Austria and securing a new gas permit offshore Italy.

Income Asset Management delivered steady revenue of $4.0 million in Q2 FY2025 alongside significant growth in funds under administration and client accounts, while retiring $10 million in debt to reduce interest costs.

Fertoz Limited reports solid Q4 2024 sales despite Canadian permit delays and plans a strategic rebrand to Canadian Phosphate Limited to align with its growth ambitions.